NSHIFT
7.8.2024 12:44:28 CEST | Business Wire | Press release
A failure to master the omnichannel experience may have dented the success of summer sales, a new report suggests. nShift argues that retailers must learn lessons from the summer and apply these lessons to Black Friday and Christmas preparations. To do this well, they need a paradigm shift in how they think about deliveries.
nShift is the global leader in delivery and experience management (DMXM). It leads the way in post-purchase experience management and multi-carrier shipping software. In a new report, “Learning from summer sales” nShift explores how retailers would like to do better at:
- Mastering the omnichannel experience – by facilitating ways for online and instore to work together, retailers can compete for a bigger slice of the bargain-hunting pie during major sales events
- Focus on customer loyalty – many retailers believe they missed opportunities to build stronger connections with customers. Anything that retailers can do to create a positive experience with first-time customers opens the door to a longer-term relationship
- Learning from data – part of the problem is that a great deal of relevant data from the delivery process sits in different systems and sometimes, different organizations
- Delivering scale and capacity – some 85% of online shoppers claim that a poor delivery experience would prevent them from ordering from that retailer again.1 But during periods of high demand, some retailers struggle to deliver
- International shipping - online shoppers increasingly expect to buy from retailers located anywhere in the world. It’s crucial that warehouses can easily ship beyond borders and keep shoppers up to date with the status of their delivery
Sean Sherwin-Smith, post-purchase product director at nShift, said: “By reflecting on what did and didn’t work well during the summer sales season, retailers can make changes ahead of the all-important ‘peak season’ toward the end of the year. The final months of 2024, which include Singles’ Day, Black Friday and the Christmas shopping season represent a huge sales opportunity for retailers. It’s often where they make the majority of their profits.
“Too often, retailers ignore how the delivery experience can help them boost their performance. Deliveries are typically dismissed as a solely logistical consideration – a world of boxes and parcels. In reality, deliveries hold the keys to unlocking customer loyalty, increasing revenue and improving operations. Creating the right delivery experience will be essential to reaching peak performance.”
The report shows how delivery & experience management (DMXM) with nShift should be central to learning the lessons from summer sales and applying them to peak-season strategies. It combines the core components of delivery management, such as a library of 1000+ carrier connections, with customer-facing applications that manage checkout and returns interfaces and customer communications. This makes it possible for retailers to create a connected delivery experience from checkout to doorstep.
Read the full report “Learning from summer sales: how delivery & experience management (DMXM) can help retailers perfect their peak-season offer by applying lessons from June discounts”
nShift. Worry less. Ship smarter. www.nshift.com
1 https://www.ipsos.com/en/ecommerce-marketplaces-delivery-experience
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807365966/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
